Cullen/Frost Bankers’s Definitive Healthcare DH Stock Holding History

Cullen/Frost Bankers’s Portfolio DH Stock Details DH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-223	Closed	-$2.3K	–	1161
2023 Q1	$2.3K	Buy	+223	New	+$2.63K	﹤0.01%	1090

Other funds holding DH

Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Cullen/Frost Bankers's DH Position: Q2 2023 in Review

Cullen/Frost Bankers sold out of Definitive Healthcare (DH) in Q2 2023, closing a stake of 223 shares — an estimated $2.3K sold.

Cullen/Frost Bankers first reported a position in DH in Q1 2023 and held it in 1 quarter. The position peaked at $2.3K in Q1 2023. 137 funds tracked by Wall St. Rank hold DH as of Q2 2023.

Cullen/Frost Bankers reported no remaining Definitive Healthcare position as of Q2 2023 after selling out during the quarter.
Cullen/Frost Bankers sold 223 Definitive Healthcare shares in Q2 2023, an estimated $2.3K.
Cullen/Frost Bankers first reported a position in Definitive Healthcare in Q1 2023 and held it in 1 quarter.
Cullen/Frost Bankers's Definitive Healthcare position peaked at $2.3K in Q1 2023.
137 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2023.

Based on Cullen/Frost Bankers's 13F filing for Q2 2023, filed 4 Aug 2023.